Clinical & Experimental Cardiology
Open Access

Ten powerful trends that will transform CV practice in the future

5^th International Conference on Clinical & Experimental Cardiology

April 27-29, 2015 Philadelphia, USA

John C (Jack) Lewin

Posters-Accepted Abstracts: J Clin Exp Cardiolog

Abstract :

While cardiovascular (CV) disease remains the number one cause of global mortality, there has been a stunning 30% reduction in CV morbidity and mortality in the US since 2000, along with a parallel 40% reduction in congenital heart disease mortality. CV diagnostic and therapeutic science and clinical progress continues at a breathtaking pace, even though governmental regulatory costs and barriers present challenges to ongoing innovation. At the same time, rising costs of CV care represent a growing financial burden for patients, businesses, and government. As a result, transformation of CV care delivery systems and payment models, made possible in large part due to progress in information technology and health data analytics, is moving forward as fast or faster than CV science is progressing. Along with genomics and genetics, CV prevention science and strategy is also rapidly evolving. Combined, these trends will significantly affect cardiovascular health and health care in the next decade. Dominant trends shaping the future of heart disease prevention, early detection, and medical management will be described and discussed in this presentation.